{"id":2234,"date":"2017-11-23T21:11:47","date_gmt":"2017-11-23T21:11:47","guid":{"rendered":"https:\/\/clinicaltrialscanada.com\/?p=2234"},"modified":"2023-01-06T21:19:13","modified_gmt":"2023-01-06T21:19:13","slug":"are-fatty-acids-in-our-blood-a-predictor-for-type-2-diabetes","status":"publish","type":"post","link":"https:\/\/clinicaltrialscanada.com\/are-fatty-acids-in-our-blood-a-predictor-for-type-2-diabetes\/","title":{"rendered":"Are Fatty Acids in Our Blood a Predictor for Type 2 Diabetes?"},"content":{"rendered":"\n
\n

In a recently published study in PLOS Medicine,<\/em> a team of researchers investigated a new way to determine whether a patient may be developing type 2 diabetes. They believe that through early detection, patients may be able to prevent or delay the onset of diabetes through behavioral changes in diet and exercise.<\/p>\n

Since the development of type 2 diabetes is often the result of a poor diet and lack of exercise, the researchers evaluated levels of 27 types of fatty acids commonly found in the blood to determine a pattern among those who developed type 2 diabetes. They found a specific fatty acid combination that was strongly predictive of type 2 diabetes.<\/p>\n

To read more about type 2 diabetes, click here<\/a>.<\/p>\n<\/div><\/div>\n\n\n\n


\n","protected":false},"excerpt":{"rendered":"

In a recently published study in PLOS Medicine, a team of researchers investigated a new way to determine whether a patient may be developing type 2 diabetes. They believe that through early detection, patients may be able to prevent or delay the onset of diabetes through behavioral changes in diet and exercise. Since the development of type […]<\/p>\n","protected":false},"author":1,"featured_media":2238,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[],"_links":{"self":[{"href":"https:\/\/clinicaltrialscanada.com\/wp-json\/wp\/v2\/posts\/2234"}],"collection":[{"href":"https:\/\/clinicaltrialscanada.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinicaltrialscanada.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinicaltrialscanada.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/clinicaltrialscanada.com\/wp-json\/wp\/v2\/comments?post=2234"}],"version-history":[{"count":3,"href":"https:\/\/clinicaltrialscanada.com\/wp-json\/wp\/v2\/posts\/2234\/revisions"}],"predecessor-version":[{"id":2239,"href":"https:\/\/clinicaltrialscanada.com\/wp-json\/wp\/v2\/posts\/2234\/revisions\/2239"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clinicaltrialscanada.com\/wp-json\/wp\/v2\/media\/2238"}],"wp:attachment":[{"href":"https:\/\/clinicaltrialscanada.com\/wp-json\/wp\/v2\/media?parent=2234"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinicaltrialscanada.com\/wp-json\/wp\/v2\/categories?post=2234"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinicaltrialscanada.com\/wp-json\/wp\/v2\/tags?post=2234"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}